Atlas Trials

Dose-adjusted Adjuvant FEC Compared to Standard FEC for Breast Cancer

Clinical trial NCT03888677 · COMPLETED

Trial details

NCT number
NCT03888677
Sponsor
Henrik Lindman
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Breast Cancer
Start date
2001-02-01
Primary completion
2003-08-01
Enrollment
1535

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.